Kiromic Biopharma, Inc. Operating Expenses
Kiromic Biopharma, Inc. reported Operating Expenses of $23.77 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2025-02-14
- Kiromic Biopharma, Inc. operating expenses for the quarter ending 2024-12-31 was $5.71M, a 7.30% increase year-over-year.
- Kiromic Biopharma, Inc. operating expenses for the quarter ending 2024-09-30 was $6.60M, a 18.93% increase year-over-year.
- Kiromic Biopharma, Inc. operating expenses for the quarter ending 2024-06-30 was $6.35M, a 47.99% increase year-over-year.
- Kiromic Biopharma, Inc. operating expenses for the quarter ending 2024-03-31 was $5.11M, a 7.03% increase year-over-year.
- Kiromic Biopharma, Inc. operating expenses for fiscal 2024 was $23.77M, a 19.23% increase from fiscal 2023.
- Kiromic Biopharma, Inc. operating expenses for fiscal 2023 was $19.94M, a 35.92% decline from fiscal 2022.
- Kiromic Biopharma, Inc. operating expenses for fiscal 2022 was $31.11M, a 20.90% increase from fiscal 2021.
- Kiromic Biopharma, Inc. operating expenses for fiscal 2021 was $25.74M, a 34.06% increase from fiscal 2020.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $12.31M derived: sum of 2 quarters · filed 2025-02-14 | $18.66M derived: sum of 3 quarters · filed 2025-02-14 | $23.77M 10-K · filed 2025-02-14 | ||||
| 2024-09-30 | $6.60M 10-Q · filed 2024-11-08 | $12.96M derived: sum of 2 quarters · filed 2024-11-08 | $18.07M 10-Q · filed 2024-11-08 | $23.39M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2024-06-30 | $6.35M 10-Q · filed 2024-08-09 | $11.47M 10-Q · filed 2024-08-09 | $16.78M derived: sum of 3 quarters · filed 2025-02-14 | $22.34M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2024-03-31 | $5.11M 10-Q · filed 2024-05-10 | $10.43M derived: sum of 2 quarters · filed 2025-02-14 | $15.98M derived: sum of 3 quarters · filed 2025-02-14 | $20.27M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-12-31 | $5.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $10.87M derived: sum of 2 quarters · filed 2025-02-14 | $15.16M derived: sum of 3 quarters · filed 2025-02-14 | $19.94M 10-K · filed 2025-02-14 | $19.94M 10-K · filed 2024-03-19 | |||
| 2023-09-30 | $5.55M 10-Q · filed 2024-11-08 | $5.55M 10-Q · filed 2023-11-14 | $9.85M derived: sum of 2 quarters · filed 2024-11-08 | $14.62M 10-Q · filed 2024-11-08 | $14.62M 10-Q · filed 2023-11-14 | $21.54M derived: sum of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | $4.29M 10-Q · filed 2024-08-09 | $4.29M 10-Q · filed 2023-08-14 | $9.07M 10-Q · filed 2024-08-09 | $9.07M 10-Q · filed 2023-08-14 | $15.99M derived: sum of 3 quarters · filed 2024-08-09 | $24.39M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $4.78M 10-Q · filed 2024-05-10 | $4.78M 10-Q · filed 2023-05-15 | $11.70M derived: sum of 2 quarters · filed 2024-05-10 | $20.09M derived: sum of 3 quarters · filed 2024-05-10 | $28.53M derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $15.32M derived: sum of 2 quarters · filed 2024-03-19 | $23.75M derived: sum of 3 quarters · filed 2024-03-19 | $31.11M 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | $8.40M 10-Q · filed 2023-11-14 | $16.83M derived: sum of 2 quarters · filed 2023-11-14 | $24.19M 10-Q · filed 2023-11-14 | $34.86M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $8.43M 10-Q · filed 2023-08-14 | $15.80M 10-Q · filed 2023-08-14 | $26.46M derived: sum of 3 quarters · filed 2023-08-14 | $32.60M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $7.37M 10-Q · filed 2023-05-15 | $18.03M derived: sum of 2 quarters · filed 2023-05-15 | $24.17M derived: sum of 3 quarters · filed 2023-05-15 | $29.14M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $10.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $16.81M derived: sum of 2 quarters · filed 2023-04-17 | $21.78M derived: sum of 3 quarters · filed 2023-04-17 | $25.74M 10-K · filed 2023-04-17 | ||||
| 2021-09-30 | $6.14M 10-Q · filed 2022-11-14 | $11.11M derived: sum of 2 quarters · filed 2022-11-14 | $15.07M 10-Q · filed 2022-11-14 | $18.63M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $4.97M 10-Q · filed 2022-08-12 | $8.93M 10-Q · filed 2022-08-12 | $12.49M derived: sum of 3 quarters · filed 2022-08-12 | $14.91M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $3.96M 10-Q · filed 2022-05-13 | $7.52M derived: sum of 2 quarters · filed 2022-05-13 | $9.93M derived: sum of 3 quarters · filed 2022-05-13 | $21.30M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $5.98M derived: sum of 2 quarters · filed 2022-04-08 | $17.34M derived: sum of 3 quarters · filed 2022-04-08 | $19.20M 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | $2.42M 10-Q · filed 2022-03-11 | $13.78M derived: sum of 2 quarters · filed 2022-03-11 | $15.64M 10-Q · filed 2022-03-11 | $17.80M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | $11.37M 10-Q · filed 2021-08-13 | $13.22M 10-Q · filed 2021-08-13 | $15.39M derived: sum of 3 quarters · filed 2021-08-13 | $16.27M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $1.85M 10-Q · filed 2021-05-14 | $4.02M derived: sum of 2 quarters · filed 2021-05-14 | $4.90M derived: sum of 3 quarters · filed 2021-05-14 | |||||
| 2019-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $3.05M derived: sum of 2 quarters · filed 2021-03-31 | $3.71M 10-K · filed 2021-03-31 | |||||
| 2019-09-30 | $879.50K 10-Q · filed 2020-11-30 | $1.54M 10-Q · filed 2020-11-30 |